|
|
Volumn 12, Issue 4, 2002, Pages 557-560
|
|
Synthesis, hydrolytic activation and cytotoxicity of etoposide prodrugs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BUFFER;
CARBOXYLESTERASE;
ETOPOSIDE;
GYRASE INHIBITOR;
PRODRUG;
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
ESTERASE;
NUCLEIC ACID SYNTHESIS INHIBITOR;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BINDING AFFINITY;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG EFFECT;
DRUG HYDROLYSIS;
DRUG PROTEIN BINDING;
DRUG STABILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
NUCLEAR MAGNETIC RESONANCE;
PH;
SERUM;
TUMOR CELL LINE;
ANIMAL;
CELL CULTURE;
CELL SURVIVAL;
HYDROLYSIS;
METABOLISM;
SWINE;
SYNTHESIS;
ANIMALS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARBOXYLESTERASE;
CARBOXYLIC ESTER HYDROLASES;
CELL SURVIVAL;
ESTERASES;
ETOPOSIDE;
HUMANS;
HYDROGEN-ION CONCENTRATION;
HYDROLYSIS;
INHIBITORY CONCENTRATION 50;
NUCLEIC ACID SYNTHESIS INHIBITORS;
PRODRUGS;
SWINE;
TUMOR CELLS, CULTURED;
|
|
EID: 0037169983
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00801-0 Document Type: Article |
|
Times cited : (24)
|
|
References (17)
|
